• This record comes from PubMed

Chlorambucil conjugates of dinuclear p-cymene ruthenium trithiolato complexes: synthesis, characterization and cytotoxicity study in vitro and in vivo

. 2016 Jul ; 21 (4) : 443-52. [epub] 20160404

Language English Country Germany Media print-electronic

Document type Journal Article

Links

PubMed 27040952
DOI 10.1007/s00775-016-1353-z
PII: 10.1007/s00775-016-1353-z
Knihovny.cz E-resources

Four diruthenium trithiolato chlorambucil conjugates have been prepared via Steglich esterification from chlorambucil and the corresponding trithiolato precursors. All conjugates are highly cytotoxic towards human ovarian A2780 and A2780cisR cancer cell lines with IC50 values in the nanomolar range. The conjugates exhibit selectivity towards A2780 cells as compared to non-cancerous HEK293 cells, while being only slightly selective for RF24 and A2780cisR cells. In vivo, the conjugate [10]BF4 suppressed the growth of a solid Ehrlich tumor in immunocompetent NMRI mice but did not prolong their overall survival. The reactivity of the chlorambucil conjugates with glutathione, a potential target of the dinuclear ruthenium motive, and with the 2-deoxyguanosine 5'-monophosphate (dGMP-a model target of chlorambucil) was studied by mass spectrometry and NMR spectroscopy. The conjugates did not show catalytic activity for the oxidation of glutathione nor binding to nucleotides, indicating that glutathione oxidation and DNA alkylation are not key mechanisms of action. Four highly cytotoxic diruthenium trithiolato chlorambucil conjugates have been prepared. All conjugates exhibit selectivity towards A2780 cells as compared to HEK293 cells, while being only slightly active in RF24 and A2780cisR cells. In vivo, the best candidate suppressed the growth of a solid Ehrlich tumor in immunocompetent NMRI mice but did not prolong their overall survival.

See more in PubMed

J Biol Inorg Chem. 2012 Aug;17(6):951-60 PubMed

Acta Crystallogr E Crystallogr Commun. 2015 Sep 26;71(Pt 10):1216-8 PubMed

Angew Chem Int Ed Engl. 2009;48(21):3854-7 PubMed

Clin Lymphoma Myeloma Leuk. 2011 Jun;11 Suppl 1:S2-6 PubMed

Inorg Chem. 2011 Nov 7;50(21):10552-4 PubMed

Dalton Trans. 2007 Nov 21;(43):4903-17 PubMed

Curr Opin Chem Biol. 2008 Apr;12(2):197-206 PubMed

Curr Med Chem. 2006;13(9):1085-107 PubMed

Pharmacol Biochem Behav. 1994 Nov;49(3):621-4 PubMed

Angew Chem Int Ed Engl. 2011 Jul 25;50(31):7124-7 PubMed

J Inorg Biochem. 2010 Jan;104(1):79-86 PubMed

Cancer Res. 1970 Jun;30(6):1799-802 PubMed

N Engl J Med. 2000 Dec 14;343(24):1750-7 PubMed

Dalton Trans. 2009 Oct 7;(37):7588-98 PubMed

Dalton Trans. 2010 Feb 21;39(7):1673-88 PubMed

J Med Chem. 2005 Jun 16;48(12):4161-71 PubMed

Inorg Chem. 2013 Nov 4;52(21):12276-91 PubMed

Dalton Trans. 2011 Nov 7;40(41):10793-800 PubMed

Chemistry. 2013 Jul 8;19(28):9297-307 PubMed

Clin Cancer Res. 2001 Mar;7(3):454-61 PubMed

Dalton Trans. 2015 Feb 28;44(8):3614-23 PubMed

Arch Pharm (Weinheim). 2007 Mar;340(3):117-26 PubMed

Dalton Trans. 2010 Nov 14;39(42):10305-13 PubMed

Chem Res Toxicol. 2009 Aug;22(8):1435-46 PubMed

Oncogene. 2013 Jan 17;32(3):363-74 PubMed

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...